Bitterman Kevin — SEC insider filings
SEC reporting owner CIK 1591747. 28 insider filings on record with FilingPulse; latest filed 2026-10-21.
Transaction summary — filings shown
Covers all 28 filings on record, filed 2020-10-14 to 2026-10-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 222,223 shares, $8,000,028 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 98 legs across 21 filings — 908,631 shares, $65,815,114 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 14.
- Largest priced transaction: purchase of 222,223 shares @ $36.00 ($8,000,028) in Disc Medicine, Inc., filed 2024-06-20.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Disc Medicine, Inc. (IRON) | Director | 25 | 1 leg · 222,223 sh · $8,000,028 | 95 legs · 878,142 sh · $64,979,413 | 13 |
| Akero Therapeutics, Inc. (AKRO) | Director | 3 | — | 3 legs · 30,489 sh · $835,701 | 1 |
Insider filings — Bitterman Kevin
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-21 | 4 | Disc Medicine, Inc. (IRON) | Sale (S): 5,937 @ $79.97 · Sale (S): 4,942 @ $79.97 · Sale (S): 115 @ $79.97 · Sale (S): 2,869 @ $79.95 · Sale (S): 2,388 @ $79.95 · Sale (S): 55 @ $79.95 · +3 more | EDGAR |
| 2026-09-15 | 4 | Disc Medicine, Inc. (IRON) | Option exercise (M): 7,136 @ $45.69 · Option exercise (M): 10,000 @ $38.85 · Option exercise (M): 10,000 @ $50.86 · Sale (S): 27,136 @ $70.11 · Option exercise (M): 7,136 (derivative) @ $0 · Option exercise (M): 10,000 (derivative) @ $0 · +1 more | EDGAR |
| 2026-09-09 | 4 | Disc Medicine, Inc. (IRON) | Sale (S): 912 @ $79.96 · Sale (S): 759 @ $79.96 · Sale (S): 18 @ $79.96 | EDGAR |
| 2026-09-03 | 4 | Disc Medicine, Inc. (IRON) | Sale (S): 70 @ $79.95 · Sale (S): 58 @ $79.95 · Sale (S): 1 @ $79.95 · Sale (S): 26,542 @ $80.17 · Sale (S): 22,090 @ $80.17 · Sale (S): 511 @ $80.17 · +6 more | EDGAR |
| 2026-06-23 | 4 | Disc Medicine, Inc. (IRON) | Grant/award (A): 6,212 (derivative) @ $0 | EDGAR |
| 2025-12-18 | 4 | Disc Medicine, Inc. (IRON) | Sale (S): 393 @ $91.47 · Sale (S): 213 @ $91.47 · Sale (S): 148 @ $91.47 | EDGAR |
| 2025-12-16 | 4 | Disc Medicine, Inc. (IRON) | Sale (S): 16,403 @ $92.05 · Sale (S): 3,852 @ $92.58 · Sale (S): 3,446 @ $93.80 · Sale (S): 8,527 @ $92.05 · Sale (S): 2,005 @ $92.58 · Sale (S): 1,793 @ $93.80 · +15 more | EDGAR |
| 2025-10-17 | 4 | Disc Medicine, Inc. (IRON) | Sale (S): 19,542 @ $77.16 · Sale (S): 2,618 @ $77.76 · Sale (S): 1,425 @ $77.11 · Sale (S): 1,125 @ $84.89 · Sale (S): 1,125 @ $84.89 · Sale (S): 3,000 @ $86.13 · +11 more | EDGAR |
| 2025-10-09 | 4 | Disc Medicine, Inc. (IRON) | Sale (S): 11,378 @ $68.01 · Sale (S): 6,661 @ $69.01 · Sale (S): 8,219 @ $68.26 · Sale (S): 12,386 @ $69.31 · Sale (S): 25,400 @ $70.54 · Sale (S): 12,689 @ $71.51 · +1 more | EDGAR |
| 2025-08-26 | 4 | Disc Medicine, Inc. (IRON) | Sale (S): 2,287 @ $61.03 | EDGAR |
| 2025-08-15 | 4 | Disc Medicine, Inc. (IRON) | Sale (S): 24,962 @ $61.15 · Sale (S): 7,212 @ $60.99 | EDGAR |
| 2025-08-07 | 4 | Disc Medicine, Inc. (IRON) | Sale (S): 395 @ $60.95 | EDGAR |
| 2025-08-01 | 4 | Disc Medicine, Inc. (IRON) | Sale (S): 8,492 @ $61.04 | EDGAR |
| 2025-07-25 | 4 | Disc Medicine, Inc. (IRON) | Sale (S): 29,837 @ $60.97 · Sale (S): 13,033 @ $61.17 | EDGAR |
| 2025-07-22 | 4 | Disc Medicine, Inc. (IRON) | Sale (S): 664 @ $61.13 | EDGAR |
| 2025-06-13 | 4 | Disc Medicine, Inc. (IRON) | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2024-06-20 | 4 | Disc Medicine, Inc. (IRON) | Purchase (P): 222,223 @ $36 | EDGAR |
| 2024-06-14 | 4 | Disc Medicine, Inc. (IRON) | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2024-03-07 | 4 | Disc Medicine, Inc. (IRON) | Sale (S): 26,157 @ $73.50 | EDGAR |
| 2024-01-25 | 4 | Disc Medicine, Inc. (IRON) | Sale (S): 82,500 @ $67.65 · Sale (S): 20,000 @ $67.65 | EDGAR |
| 2024-01-12 | 4 | Disc Medicine, Inc. (IRON) | Sale (S): 20,000 @ $64 | EDGAR |
| 2023-12-14 | 4 | Disc Medicine, Inc. (IRON) | Sale (S): 20,823 @ $59.87 · Sale (S): 422 @ $60.99 · Sale (S): 4,155 @ $62.42 · Sale (S): 665 @ $62.90 · Sale (S): 688 @ $63.78 · Sale (S): 18,615 @ $65.10 · +5 more | EDGAR |
| 2023-08-17 | 4 | Disc Medicine, Inc. (IRON) | Sale (S): 72,931 @ $52.40 | EDGAR |
| 2023-06-09 | 4 | Disc Medicine, Inc. (IRON) | Grant/award (A): 7,136 (derivative) @ $0 | EDGAR |
| 2023-01-03 | 4 | Disc Medicine, Inc. (IRON) | Grant/award (A): 7,000 (derivative) @ $0 | EDGAR |
| 2021-06-03 | 4 | Akero Therapeutics, Inc. (AKRO) | Grant/award (A): 13,000 (derivative) @ $0 | EDGAR |
| 2021-06-03 | 4 | Akero Therapeutics, Inc. (AKRO) | Sale (S): 16,544 @ $26.28 · Sale (S): 945 @ $26.28 | EDGAR |
| 2020-10-14 | 4 | Akero Therapeutics, Inc. (AKRO) | Sale (S): 13,000 @ $28.93 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-13 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1591747 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs